Skip to main content

Table 3 Univariable analysis of association with biochemical failure and distant metastasis

From: The role of androgen deprivation therapy on biochemical failure and distant metastasis in intermediate-risk prostate cancer: effects of radiation dose escalation

  Biochemical failure Distant metastasis
Variable Hazard 95% CI p-value Hazard 95% CI p-value
  Ratio    Ratio   
Age 1.000 0.980-1.02 0.983 1.016 0.968-1.067 0.522
Pre-treatment PSA 1.075 1.045-1.106 <0.001 1.043 0.975-1.115 0.22
Gleason Score 0.863 0.761-0.978 0.021 1.100 0.796-1.519 0.564
Year of Diagnosis 0.902 0.875-0.930 <0.001 0.926 0.858-0.999 0.046
T-stage 1.215 1.043-1.416 0.012 1.668 1.125-2.474 0.011
Radiation Dose (high vs low) 0.431 0.320-0.581 <0.001 0.593 0.287-1.226 0.158
ADT use (yes vs no) 0.422 0.274-0.651 <0.001 0.119 0.016-0.882 0.037
Length of Hormone use 0.981 0.938-1.026 0.403 1.000 0.914-1.094 0.997
Race 0.795 0.611-1.034 0.087 0.678 0.318-1.444 0.263
ADT Timing (Neoadjuvant vs adjuvant) 1.514 0.444-5.160 0.507 1.047 0.408-2.688 0.924